• FDA approves Sanofi’s heart drug, Multaq. This is the first major FDA approval for Sanofi since 2002. [Bloomberg]

• Cannabis Science hires IR firm, will weed out non-interested investors. [Silicon Beat]

• Genentech’s Lucentis works in patients with retinal vein occlusion . [Bloomberg]

• A sobering look at the biotech damage thus far. [Life Science Leader]

• Teva: Another day, another patent infringement lawsuit. [CNN Money]

• Jobs jobs jobs at Eisai!!! [Business Weekly]

• Surfaxin continues to bring headaches to Discovery Laboratories (DSCO). [WSJ]

• Finally, the IN VIVO Blog takes a look inside some biotech deals and talks with Barbara Kosacz, head of Cooley Godward Kronish’s Life Sciences Practice. [The IN VIVO Blog]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts